These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 30131343)

  • 1. Complement-mediated thrombotic microangiopathy associated with lupus nephritis.
    Park MH; Caselman N; Ulmer S; Weitz IC
    Blood Adv; 2018 Aug; 2(16):2090-2094. PubMed ID: 30131343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
    Kotzen ES; Roy S; Jain K
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of renal thrombotic microangiopathy in lupus nephritis.
    Song D; Wu LH; Wang FM; Yang XW; Zhu D; Chen M; Yu F; Liu G; Zhao MH
    Arthritis Res Ther; 2013 Jan; 15(1):R12. PubMed ID: 23320601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy.
    Wright RD; Bannerman F; Beresford MW; Oni L
    BMC Nephrol; 2020 Jun; 21(1):245. PubMed ID: 32605540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M; Ohashi N; Namikawa A; Katahashi N; Ishigaki S; Tsuji N; Isobe S; Iwakura T; Sakao Y; Tsuji T; Kato A; Fujigaki Y; Shimizu A; Yasuda H
    Intern Med; 2018 Jun; 57(11):1617-1623. PubMed ID: 29434134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Complement in Autoimmune Disease-Associated Thrombotic Microangiopathy and the Potential for Therapeutics.
    Java A; Kim AHJ
    J Rheumatol; 2023 Jun; 50(6):730-740. PubMed ID: 36642429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
    Mejia-Vilet JM; Gómez-Ruiz IA; Cruz C; Méndez-Pérez RA; Comunidad-Bonilla RA; Uribe-Uribe NO; Nuñez-Alvarez CA; Morales-Buenrostro LE
    Clin Rheumatol; 2021 Jun; 40(6):2233-2242. PubMed ID: 33170371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
    Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
    Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal thrombotic microangiopathy and antiphospholipid syndrome nephropathy in a patient with lupus nephritis].
    Sakamaki Y; Konishi K; Hashiguchi A; Tomita S; Kubota E; Itoh H; Hayashi K
    Nihon Jinzo Gakkai Shi; 2016; 58(1):45-54. PubMed ID: 26950981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
    Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].
    Fani FM; Patera A; Delsante M; Rossi GM; Manenti L; Landini S; Regolisti G; Fiaccadori E
    G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review.
    de Holanda MI; Pôrto LC; Wagner T; Christiani LF; Palma LMP
    Clin Rheumatol; 2017 Dec; 36(12):2859-2867. PubMed ID: 28905254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V; Fakhouri F; Roumenina L; Dragon-Durey MA; Loirat C
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis
    Zhang B; Xing G
    Front Immunol; 2022; 13():1081942. PubMed ID: 36582241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapidly progressive lupus nephritis and concomitant thrombotic microangiopathy.
    Gharbi C; Bourry E; Rouvier P; Hacini S; Letaief A; Baumelou A; Izzedine H
    Clin Exp Nephrol; 2010 Oct; 14(5):487-91. PubMed ID: 20535626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab.
    Raufi AG; Scott S; Darwish O; Harley K; Kahlon K; Desai S; Lu Y; Tran MH
    Hematol Rep; 2016 Sep; 8(3):6625. PubMed ID: 27781079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities.
    Timmermans SAMEG; Abdul-Hamid MA; Vanderlocht J; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P;
    Kidney Int; 2017 Jun; 91(6):1420-1425. PubMed ID: 28187980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
    Front Immunol; 2022; 13():909503. PubMed ID: 35720299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.